Innovation is our key pillar for business continuity since inception and we strive to continuously innovate in the area of product development. With this special focus on R &D, today we have top-notch team working with Lofty and are collectively driving efforts towards expanding our product portfolio.

Our R&D facility has all the required state-of-the-art equipment for formulation development and working on different dosage forms. With these capabilities and focus areas, we are able to bring products to market efficiently at a shorter notice. With this core strength we are driving our efforts in the areas of Advanced Intermediates, APIs, Oncology, and Biosimilars. We have 10+ molecules in our R&D pipeline.